TWI371281B - Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor - Google Patents
Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitorInfo
- Publication number
- TWI371281B TWI371281B TW095131384A TW95131384A TWI371281B TW I371281 B TWI371281 B TW I371281B TW 095131384 A TW095131384 A TW 095131384A TW 95131384 A TW95131384 A TW 95131384A TW I371281 B TWI371281 B TW I371281B
- Authority
- TW
- Taiwan
- Prior art keywords
- muscle pain
- pain inhibitor
- manufacture
- fermented milk
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005246312 | 2005-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200740444A TW200740444A (en) | 2007-11-01 |
TWI371281B true TWI371281B (en) | 2012-09-01 |
Family
ID=37771639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095131384A TWI371281B (en) | 2005-08-26 | 2006-08-25 | Use of fermented milk for manufacture of muscle pain inhibitor and muscle pain inhibitor |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5198865B2 (zh) |
TW (1) | TWI371281B (zh) |
WO (1) | WO2007023896A1 (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0770209A (ja) * | 1993-07-02 | 1995-03-14 | Takeda Shokuhin Kogyo Kk | 多糖物質nps、その製造法および用途 |
AU7267094A (en) * | 1993-07-28 | 1995-02-28 | Rhone-Poulenc Rorer Limited | Compounds as pde iv and tnf inhibitors |
CA2321737A1 (en) * | 1998-03-04 | 1999-09-10 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
AU6402700A (en) * | 1999-07-09 | 2001-01-30 | Monsanto Company | Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
JP4448447B2 (ja) * | 2002-08-21 | 2010-04-07 | キッセイ薬品工業株式会社 | 筋肉疲労若しくは筋肉損傷およびそれらに起因する疾患の予防治療用組成物 |
US20040204411A1 (en) * | 2002-12-17 | 2004-10-14 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
JP4680571B2 (ja) * | 2003-12-25 | 2011-05-11 | カルピス株式会社 | 経口摂取用保湿剤 |
-
2006
- 2006-08-24 JP JP2007532167A patent/JP5198865B2/ja not_active Expired - Fee Related
- 2006-08-24 WO PCT/JP2006/316610 patent/WO2007023896A1/ja active Application Filing
- 2006-08-25 TW TW095131384A patent/TWI371281B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPWO2007023896A1 (ja) | 2009-02-26 |
TW200740444A (en) | 2007-11-01 |
WO2007023896A1 (ja) | 2007-03-01 |
JP5198865B2 (ja) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2099321A4 (en) | Nutmeg compositions and methods for their preparation and use | |
HK1118186A1 (en) | Osteosynthetic implants and methods of use and manufacture | |
IL176958A0 (en) | Compounds and methods of use | |
GB0610867D0 (en) | Treatment of pain | |
EP1827391A4 (en) | DOSAGE FORMS AND METHODS OF USE THEREOF | |
EP1786264A4 (en) | CATIONIC ANTISEPTIC COMPOSITIONS AND METHOD FOR THEIR USE | |
EP1933880A4 (en) | OLIGORIBONUCLEOTIDES AND METHODS OF USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES | |
HK1145406A1 (zh) | 新型細菌及其使用方法 | |
PT2099321T (pt) | Composições de leite humano e métodos de fabrico e utilização das mesmas | |
IL213843A0 (en) | 4-aminotetracyclines and methods of use thereof | |
EP2091588A4 (en) | CARDIAL DEVICE AND USE METHOD THEREFOR | |
IL178996A0 (en) | Thienopyridinone compounds and methods of treatment | |
IL193748A0 (en) | Treatment of pain | |
EP1838714A4 (en) | METHODS OF TREATING PAIN | |
IL182436A0 (en) | Thienopyridinone compounds and methods of treatment | |
HK1135099A1 (en) | Aza-indolyl compounds and methods of use | |
EP1909689A4 (en) | IMPLANTS CONTAINING A MEDICAMENT AND METHOD OF USE | |
EP1868607A4 (en) | ISOCHINOLINE COMPOUNDS AND APPLICATION METHOD THEREFOR | |
GB0404656D0 (en) | Treatment of spinal conditions | |
EP1812451A4 (en) | COMPOUNDS AND METHODS OF USE THEREOF | |
GB0421164D0 (en) | Medical devices and methods of making medical devices | |
IL187405A0 (en) | Methods and compositions for the treatment of pain | |
EP1735281A4 (en) | SYNTHESIS OF INDENOISOQUINOLINIUMS AND TECHNIQUES OF USE | |
EP1954800A4 (en) | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE | |
EP1928247A4 (en) | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |